Latest Articles
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer - Oncology News Central
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer Oncology News Central
Published: June 17, 2024, 7 a.m.
AstraZeneca’s Imfinzi regimen granted FDA approval to treat endometrial cancer - PMLiVE
AstraZeneca’s Imfinzi regimen granted FDA approval to treat endometrial cancer PMLiVE
Published: June 17, 2024, 7 a.m.
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Pharmaceutical Executive
Published: June 17, 2024, 7 a.m.
Adding Immunotherapy to Chemotherapy for Endometrial Cancer - Cleveland Clinic
Adding Immunotherapy to Chemotherapy for Endometrial Cancer Cleveland Clinic
Published: June 13, 2024, 7 a.m.
Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer - Cancer Therapy Advisor
Abemaciclib Plus Fulvestrant Demonstrates Activity in Advanced Endometrial Cancer Cancer Therapy Advisor
Published: June 11, 2024, 7 a.m.
Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk - SurvivorNet
Weight Loss Drugs, Like Mounjaro, Taken By RHONJ Alum, May Reduce Endometrial Cancer Risk SurvivorNet
Published: June 11, 2024, 7 a.m.
Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets - The ASCO Post
Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets The ASCO Post
Published: June 10, 2024, 7 a.m.
Endometriosis increases risks for ovarian, endometrial cancers - Healio
Endometriosis increases risks for ovarian, endometrial cancers Healio
Published: June 7, 2024, 7 a.m.
ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today
ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone Medpage Today
Published: June 5, 2024, 7 a.m.
Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis - Frontiers
Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis Frontiers
Published: June 2, 2024, 7 a.m.
Link copied to clipboard!